Similar articles

• Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.

  Olszanecka-Glinianowicz M, Kuglin D, Dąbkowska-Huć A, Skałba P. Olszanecka-Glinianowicz M, et al. Eur J Obstet Gynecol Reprod Biol. 2011 Jan;154(1):51-6. doi: 10.1016/j.ejogrb.2010.08.022. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 20889251
• Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.

  Spanos N, Tziomalos K, Macut D, Koiou E, Kandaraki EA, Delkos D, Tsourdi E, Panidis D. Spanos N, et al. Obes Facts. 2012;5(4):495-504. doi: 10.1159/000341579. Epub 2012 Jul 23. Obes Facts. 2012. PMID: 22854419
• Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome.

  Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo RA. Carmina E, et al. Fertil Steril. 2009 Apr;91(4 Suppl):1332-5. doi: 10.1016/j.fertnstert.2008.03.007. Epub 2008 May 2. Fertil Steril. 2009. PMID: 18455165
• The role of cytokines in polycystic ovarian syndrome.

  Ebejer K, Calleja-Agius J. Ebejer K, et al. Gynecol Endocrinol. 2013 Jun;29(6):536-40. doi: 10.3109/09513590.2012.760195. Epub 2013 Feb 1. Gynecol Endocrinol. 2013. PMID: 23368758 Review.
• Pathophysiology and types of dyslipidemia in PCOS.

  Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP. Diamanti-Kandarakis E, et al. Trends Endocrinol Metab. 2007 Sep;18(7):280-5. doi: 10.1016/j.tem.2007.07.004. Epub 2007 Aug 10. Trends Endocrinol Metab. 2007. PMID: 17692530 Review.